Tomohisa Yamamoto Selected Research

Tomohisa Yamamoto Research Topics

Disease

21	Adenocarcinoma 06/2022 - 04/2012
15	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 12/2007
13	Neoplasms (Cancer) 06/2022 - 04/2011
8	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2011
7	Pancreatic Fistula (Pancreatic Fistulas) 01/2019 - 08/2008
6	Lymphatic Metastasis 06/2022 - 04/2012
3	Cholangitis 11/2022 - 01/2014
3	Cholelithiasis 01/2020 - 01/2019
2	Ascites 06/2022 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2018
2	Diarrhea 01/2021 - 01/2017
2	Non-alcoholic Fatty Liver Disease 03/2016 - 03/2014
1	Pathologic Constriction (Stenosis) 11/2022
1	Malnutrition (Nutritional Deficiencies) 02/2022
1	Actinomycosis 08/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2021
1	Diabetes Mellitus 08/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Hemorrhage 10/2020
1	Cholecystolithiasis 01/2020
1	Gallbladder Diseases (Gall Bladder Disease) 04/2019
1	Acute Cholecystitis 04/2019
1	Pancreatitis 04/2019
1	Edema (Dropsy) 04/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Postoperative Cognitive Complications 01/2019
1	Hypotension (Low Blood Pressure) 01/2018
1	Median Arcuate Ligament Syndrome 12/2016
1	Fatigue 01/2016
1	Neutropenia 01/2016
1	Abdominal Abscess 01/2014
1	Cysts 11/2013
1	Fibrosis (Cirrhosis) 02/2013

Drug/Important Bio-Agent (IBA)

8	Gemcitabine FDA Link 02/2022 - 09/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 01/2017
3	Active Hexose Correlated CompoundIBA 02/2022 - 01/2016
3	CarbohydratesIBA 02/2022 - 04/2011
2	Immunologic Factors (Immunomodulators)IBA 02/2022 - 11/2021
2	130-nm albumin-bound paclitaxelIBA 02/2022 - 04/2021
2	AntigensIBA 07/2021 - 04/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2016
2	EnzymesIBA 03/2016 - 03/2014
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 02/2013
2	A 19IBA 01/2014 - 08/2008
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2020
1	Serum AlbuminIBA 01/2020
1	Perilipin-2IBA 04/2019
1	CytokinesIBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	General AnestheticsIBA 01/2019
1	folfirinoxIBA 01/2019
1	Isoflurane FDA LinkGeneric 01/2018
1	TegafurIBA 01/2017
1	PotassiumIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 09/2014
1	Angiotensin IIIBA 08/2014
1	Losartan (Cozaar)FDA LinkGeneric 08/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	fascinIBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	Prostaglandins AIBA 01/2011
1	Polyglycolic Acid (Polyglycolide)IBA 01/2011
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2011
1	Peptides (Polypeptides)IBA 09/2010

Therapy/Procedure

14	Pancreatectomy 02/2022 - 12/2007
13	Drug Therapy (Chemotherapy) 06/2022 - 02/2013
10	Therapeutics 04/2021 - 09/2010
9	Pancreaticoduodenectomy 11/2022 - 01/2014
7	Adjuvant Chemotherapy 06/2022 - 01/2016
6	Neoadjuvant Therapy 02/2022 - 11/2010
3	Laparotomy 03/2022 - 04/2011
3	Cholecystectomy 01/2020 - 01/2019
2	Combined Modality Therapy 02/2022 - 05/2020
2	Operative Surgical Procedures 08/2021 - 01/2020
2	Pancreaticojejunostomy 01/2019 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2016
2	Length of Stay 01/2019 - 01/2014
2	Anesthesia 01/2019 - 01/2018
1	Jejunostomy 11/2022
1	Preoperative Period 11/2022
1	Gastrectomy 08/2021
1	Chemoradiotherapy 05/2020
1	Laparoscopic Cholecystectomy 01/2019
1	Hepatectomy 01/2018
1	General Anesthesia 01/2018
1	Blood Transfusion (Blood Transfusions) 01/2016
1	Aftercare (After-Treatment) 02/2013